S. Mahajan

发表

PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells

A. Kraft, Fengxue Zhang, Zanna Beharry, 2009, Cancer biology & therapy.

Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]*

F. Uckun, S. Mahajan, Y. Zheng, 1999, The Journal of Biological Chemistry.

BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells

T. Kurosaki, F. Uckun, S. Mahajan, 1996, Science.

Temporal regulation of non-transmembrane protein tyrosine kinase enzyme activity following T cell antigen receptor engagement.

J. Fargnoli, A. Burkhardt, J. Bolen, 1994, The Journal of biological chemistry.

Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells

A. Kraft, S. Mahajan, Zihai Li, 2013, Stem cells.

The Anti-leukemic Bruto n's Tyrosine Kinase Inhibitor α-cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl) Propenamide (LFM-A13) Prevents Fatal Thromboembolism

F. Uckun, S. Mahajan, S. Bartell, 2003 .

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.

L. Obeid, G. Marcucci, D. Perrotti, 2011, Blood.

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl 1 stability and drug resistance by modulation of protein phosphatase 2 A *

L. Obeid, G. Marcucci, D. Perrotti, 2011 .

phosphatase 2A Bcr-Abl1 stability and drug resistance by modulation of protein Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate

L. Obeid, G. Marcucci, D. Perrotti, 2011 .

Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement.

J. Fargnoli, O. Witte, A. Burkhardt, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Specific Association of Tyrosine-phosphorylated c-Cbl with Fyn Tyrosine Kinase in T Cells*

J. Bolen, S. Mahajan, A. Tsygankov, 1996, The Journal of Biological Chemistry.

Cross-linking of surface immunoglobulin activates src-related tyrosine kinases in WEHI 231 cells.

J. Fargnoli, G. Schieven, J. Bolen, 1992, Biochemical and biophysical research communications.

Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells

A. Kraft, Fengxue Zhang, Zanna Beharry, 2009, Molecular Cancer Therapeutics.

Deletion of Pim Kinases Elevates the Cellular Levels of Reactive Oxygen Species and Sensitizes to K-Ras-Induced Cell Killing

S. Mehrotra, A. Kraft, Jin H. Song, 2014, Oncogene.

The Pim protein kinases regulate energy metabolism and cell growth

A. Kraft, Zanna Beharry, Charles D Smith, 2010, Proceedings of the National Academy of Sciences.

Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase

J. Fargnoli, A. Burkhardt, J. Bolen, 1995, Molecular and cellular biology.

In vivo Toxicity and Antithrombotic Profile of the Oral Formulation of the Antileukemic Agent, LFM-A13-F

F. Uckun, S. Mahajan, P. Samuel, 2004, Arzneimittelforschung.

Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta

M. Nussenzweig, A. Burkhardt, J. Bolen, 1993, The Journal of experimental medicine.

Bruton’s Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex*

F. Uckun, S. Mahajan, A. Vassilev, 1999, The Journal of Biological Chemistry.

Involvement of nonreceptor protein tyrosine kinases in multichain immune recognition receptor signal transduction.

A. Burkhardt, J. Bolen, S. Mahajan, 1994, Advances in experimental medicine and biology.

Reconstitution of the B Cell Antigen Receptor Signaling Components in COS Cells (*)

J. Fargnoli, J. Bolen, S. Mahajan, 1995, The Journal of Biological Chemistry.

Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1.

A. Kraft, S. Mahajan, Wenxue Wang, 2013, Cancer research.

Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B Cells*

Fatih M. Uckun, A. Vassilev, F. Uckun, 2001, The Journal of Biological Chemistry.

The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.

F. Uckun, S. Mahajan, S. Bartell, 2003, Leukemia & lymphoma.

Hypoxia-inducible factor-2α regulates the expression of TRAIL receptor DR5 in renal cancer cells

A. Kraft, S. Mahajan, V. Dammai, 2008, Carcinogenesis.

Hypoxia-inducible factor-2 a regulates the expression of TRAIL receptor DR 5 in renal cancer cells

A. Kraft, S. Mahajan, V. Dammai, 2008 .

Signal Transduction by Immunoglobulin Is Mediated Through Igc ~ and Ig

M. Nussenzweig, A. Burkhardt, J. Bolen, 2003 .

The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling

M. Minden, A. Ebens, J. Cortes, 2014, Molecular and Cellular Biology.

Electromagnetic Field-induced Stimulation of Bruton’s Tyrosine Kinase*

T. Kurosaki, F. Uckun, S. Mahajan, 1998, The Journal of Biological Chemistry.

Regulation of Skp2 Levels by the Pim-1 Protein Kinase*

S. Cramer, A. Kraft, Zanna Beharry, 2010, The Journal of Biological Chemistry.

Signal transduction through a biomolecular receptor tyrosine protein kinase composed of a platelet-derived growth factor receptor-CD4 chimera and the nonreceptor tyrosine protein kinase Lck.

J. Escobedo, J. Bolen, S. Mahajan, 1993, The Journal of biological chemistry.

Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells

A. Kraft, Fengxue Zhang, Zanna Beharry, 2009, Molecular Cancer Therapeutics.

The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling

M. Minden, A. Ebens, J. Cortes, 2014, Molecular and Cellular Biology.